Even if the order takes effect, it will do nothing to address the root causes of the problem it purports to solve.

Less than a month after a dramatic cut to UnitedHealth Group’s guidance set off a historic selloff in the insurance giant’s ...

UnitedHealth Group earlier Tuesday suspended its earnings guidance for 2025, prompting investors to pull back on shares of the company and other names in the healthcare space.

President Donald Trump signs a sweeping executive order aimed at drastically reducing prescription drug prices in the United ...

CVS Health Corporation CVS and The Cigna Group CI shares trading lower Tuesday. President Donald Trump on Monday signed an executive order aimed at reducing the cost of prescripti ...

Blue-chip health insurer UnitedHealth (UNH) is weighing on the Dow today after a suspended guidance and C-suite shakeup ...

UnitedHealth Group announced the immediate resignation of CEO Andrew Witty for personal reasons on Tuesday and withdrew its already-slashed full-year earnings outlook, citing a continued acceleration ...

Bernstein analysts say the market has overreacted to President Trump’s latest executive order on drug pricing, arguing that the directive poses limited new risks to pharmacy benefit managers (PBMs) ...

UnitedHealth remains in fine financial shape. As of December 2024, the company owed $77 billion in debt (held at the parent level), or gross debt/EBITDA of around 2 times. The parent company typically ...

Witty will act as a senior advisor to his successor, Stephen Hemsley, who served as UnitedHealth Group’s CEO from 2006 to ...

The Most Favored Nations directive would allow drugmakers to directly sell their products to patients at a lower cost, ...

UnitedHealth Group (UNH) stock drops as its CEO steps down, and the company suspends its 2025 outlook amid rising medical ...